Research Article
[Retracted] Analysis of Risk Factors of Bronchiolitis Obliterans in Children with Mycoplasma pneumoniae Bronchiolitis
Table 1
Comparison of clinical data of two groups of children.
| | Clinical indicators | BO group (32 cases) | Group without BO (195 cases) | Statistics (//-) | value |
| | General information | | | | | | Gender (male/female) | 24/8 | 112/83 | 3.531 | 0.060 | | Age (years) | 5 (3-6) | 5 (3-7) | -0.57 | 0.569 | | Time from onset to application of macrolides (d) | 4 (3-5) | 3 (3-5) | -1.630 | 0.103 | | Family or personal allergy history (case) | 16 (50.0%) | 116 (59.5%) | 1.017 | 0.313 | | Symptoms and signs | | | | | | Fever (case) | 28 (87.5%) | 186 (95.4%) | 1.873 | 0.171 | | Hot peak (°C) | 39.6 (38.9-40) | 39.3 (39.0-39.8) | -0.150 | 0.881 | | Heat path (d) | 8.5 (6.0-10.0) | 8 (7-10) | -0.815 | 0.415 | | Respite (case) | 7 (21.9%) | 26 (13.3%) | 1.000 | 0.317 | | Shortness of breath (case) | 4 (12.5%) | 8 (4.1%) | 2.376 | 0.123 | | Hypoxemia (case) | 12 (37.5%) | 2 (1.0%) | 57.049 | ≤0.001 | | Moist rales (case) | 32 (100%) | 174 (89.2%) | 2.623 | 0.105 | | Duration of moist rales (d) | 10.5 (8.0-13.0) | 6 (4-8) | -5.127 | ≤0.001 | | Iconography | | | | | | Pleural effusion (case) | 20 (62.5%) | 40 (20.5%) | 24.922 | ≤0.001 | | Small consolidation (case) | 8 (25.0%) | 73 (37.4%) | 1.852 | 0.174 | | Lesion site (double/single) | 24/8 | 118/77 | 2.463 | 0.117 | | Number of lesions involving leaves (1) | 1 (3.1%) | 21 (10.8%) | 1.835 | 0.176 | | Number of lesions involving leaves (2) | 8 (25.0%) | 76 (39.0%) | 2.303 | 0.129 | | Number of lesions involving leaves (3) | 4 (12.5%) | 55 (28.2%) | 3.525 | 0.060 | | Number of lesions involving leaves (≥4) | 19 (59.4%) | 43 (22.0%) | 19.289 | ≤0.001 | | Coinfection | | | | | | Bacteria (case) | 4 (12.5%) | 14 (7.2%) | 0.462 | 0.497 | | Virus (case) | 4 (12.5%) | 30 (15.4%) | 0.025 | 0.876 | | Extrapulmonary complications (case) | 6 (18.8%) | 29 (19.0%) | 0.001 | 0.979 | | Skin lesion (case) | 1 (3.1%) | 2 (1.0%) | — | 0.367 | | Functional disturbance of the gastrointestinal tract (case) | 0 | 5 (2.6%) | — | 1.000 | | Electrolyte disturbance (case) | 0 | 3 (1.5%) | — | 1.000 | | Hepatic dysfunction (case) | 6 (18.8%) | 24 (12.3%) | 0.512 | 0.474 | | Myocardial damage (case) | 4 (12.5%) | 20 (10.3%) | 0.005 | 0.942 | | MP titer | | | 0.871 | 0.832 | | 1 : 160 | 1 (3.1%) | 8 (4.1%) | | | | 1 : 320 | 3 (9.4%) | 19 (9.7%) | | | | 1 : 640 | 4 (12.5%) | 15 (7.7%) | | | | 1 : 1280 | 24 (75%) | 153 (78.5%) | | | | Treatment | | | | | | Bronchoscope (case) | 21 (65.6%) | 105 (53.8%) | 1.544 | 0.214 | | Microscopic appearance: mucus plug (case) | 12 (37.5%) | 11 (5.6%) | 27.243 | ≤0.001 | | Hormone application (case) | 24 (75.0%) | 129 (66.2%) | 0.979 | 0.322 | | Time from onset to application of hormones (d) | 11 (10-12) | 10 (8.5-13.0) | -0.778 | 0.437 | | Application of noninvasive CPAP (case) | 8 (25.0%) | 2 (1.0%) | 32.041 | ≤0.001 |
|
|
